Author:
Dumont C,Wuestenberghs F,Lanthier N,Piessevaux H,Dahlqvist G
Abstract
Background and study aims: The role of malnutrition on the prognosis of hospitalized cirrhotic patients is incompletely studied. Our aim was to determine the prevalence of malnutrition, functional scores and their impact on prognosis of hospitalized cirrhotic patients.
Patients and methods: This retrospective study included all patients with cirrhosis hospitalized in the gastroenterology unit at Saint-Luc university hospital, Brussels between April 2014 and September 2014. Nutritional status was evaluated according to minimum clinical summary diagnostic criteria. Cirrhosis-related complications or death occurrence were analysed in a one-year follow-up.
Results: 95 cirrhotic patients were assessed for nutritional status and outcomes. Malnutrition affected 45.3% of patients and was more frequent with the severity of cirrhosis: 29% in Child-Pugh A, 48.8% in Child-Pugh B and 72.2% in Child-Pugh C patients. 58.9% of patients developed cirrhosis-related complications (60.7% in the malnutrition group vs. 39.3%, p<0.001, OR 5.06, IC95 1.90-14.58) and 33.7% of patients died (68.75% vs. 31.25%, p=0.002, OR 4.33, IC95 1.62-12.28). Adjusting for age, sodium, MELD, Charlson index, hepatocellular carcinoma, platelets, diabetes, prognostic nutritional index and Braden scale, malnutrition was significantly associated with higher mortality and morbidity rates with an OR of 3.56 (CI95 1.55-8.16) and 2.09 (CI95 1.16-3.77) respectively. Braden scale was significantly associated with higher mortality (p=0.027, OR 1.25, CI95 1.03-1.52) whereas prognostic nutritional index was associated with higher morbidity (p=0.001, OR 0.94, CI95 0.90- 0.98).
Conclusion: Malnutrition is highly prevalent in hospitalized cirrhotic patients. Malnutrition, low prognostic nutritional index and low Braden scale are associated with poor outcomes in cirrhosis.
Reference48 articles.
1. MOKDAD A.A., LOPEZ A.D., SHAHRAZ S., LOZANO R., MOKDAD A.H., STANAWAY J., et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014, 12: 145.
2. LANTHIER N., VANUYTSEL T., Metabolic dysfunction-associated fatty liver disease : a new clearer nomenclature with positive diagnostic criteria Acta Gastro-EnteroBelgica., 2020, 83: 513-515
3. KAZE E., DESCAMPS O., HENRION J. The changing pattern of cirrhosis in Belgium : A study based on two cohorts prospectively collected 15 years apart. Acta Gastroenterol. Belg., 2020, 83: 559-563.
4. HAMOIR C., HORSMANS Y., STARKËL P., DAHLQVIST G., NEGRIN DASTIS S., LANTHIER N., Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents. Acta Gastro-Enterol. Belg., 2021, 83: 25-32.
5. JUAKIEM W., TORRES D.M, HARRISON S.A. Nutrition in cirrhosis and chronic liver disease. Clin Liver Dis., 2014, 18: 179-190.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献